Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In this episode of the Big Questions podcast, Dr Andy Segerdahl (Wellcome Centre for Integrative Neuroimaging and Nuffield Department of Clinical Neurosciences) explains his research looking at how the brain and spinal cord process pain.

None

We all feel pain differently. What to one person may be the worst pain in the world, might be a mild irritation to another person; but why? At the moment, we don’t have a thorough understanding of how pain is processed, meaning it is difficult to devise treatments for chronic (long-term) pain.

In this episode of the ‘Big Questions’ podcast, we are lucky enough to join Dr Andy Segerdahl – a neuroscientist at the Wellcome Centre for Integrative Neuroimaging (WIN) and the Nuffield Department of Clinical Neurosciences at the University of Oxford – for one of his experiments, where he is examining pain response (in a willing volunteer!) using an fMRI scanner. As he explains, if we can fully understand which parts of the brain and spinal cord are involved in pain response in a healthy individual, we can begin to understand how this response becomes dysfunctional.

Listen to the podcast on the Oxford Sparks website

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.